- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beximco Pharmaceuticals Ltd. (BXPq)
Beximco Pharmaceuticals Ltd. stock price live, this page displays LON BXPq stock exchange data. View the BXPq premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beximco Pharmaceuticals Ltd. real time stock price chart below.
What Is the Beximco Pharmaceuticals Ltd. Stock Price Today?
The Beximco Pharmaceuticals Ltd. stock price today is 44.50.
What Is the Stock Symbol for Beximco Pharmaceuticals Ltd.?
The stock symbol for Beximco Pharmaceuticals Ltd. is ""BXPq.""
What Stock Exchange Does Beximco Pharmaceuticals Ltd. Trade On?
Beximco Pharmaceuticals Ltd. is listed and trades on the London stock exchange.
Is Beximco Pharmaceuticals Ltd. a Good Stock to Buy?
Determining whether Beximco Pharmaceuticals Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BXPq quote. (ISIN: US0885792061)
What Is the Beximco Pharmaceuticals Ltd. Stock Price Today?
The Beximco Pharmaceuticals Ltd. stock price today is 44.50.
What Is the Stock Symbol for Beximco Pharmaceuticals Ltd.?
The stock symbol for Beximco Pharmaceuticals Ltd. is ""BXPq.""
What Stock Exchange Does Beximco Pharmaceuticals Ltd. Trade On?
Beximco Pharmaceuticals Ltd. is listed and trades on the London stock exchange.
Is Beximco Pharmaceuticals Ltd. a Good Stock to Buy?
Determining whether Beximco Pharmaceuticals Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BXPq quote. (ISIN: US0885792061)
44.50
0.00(0.00%)
Closed·
Fair Value
An estimate of a Beximco Pharma.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
44.50
44.50
52 wk Range
19.33
45.00
BXPq Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
High dividend Yield
1/2
Fair Value
An estimate of a Beximco Pharma.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
44.5044.50
52 wk Range
19.3345.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.67%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.67%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BXPq Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Beximco Pharma.'s true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Beximco Pharmaceuticals Ltd. Company Profile
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Compare BXPq to Peers and Sector
Metrics to compare | BXPq | Peers Peers - average of corresponding metrics from companies closely matching BXPq: ACMELAB, SQURPHARMA, TECHNODRUG, ORIONPHARM, ORIONINFU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBXPqPeersSector |
|---|---|---|---|---|
P/E Ratio | 8.2x | 14.1x | −0.5x | |
PEG Ratio | 0.28 | −0.64 | 0.00 | |
Price/Book | 1.0x | 1.5x | 2.6x | |
Price / LTM Sales | 1.1x | 2.8x | 3.3x | |
Upside (Analyst Target) | - | 27.4% | 43.5% | |
Fair Value Upside | Unlock | 13.1% | 6.8% | Unlock |
Earnings
Latest Release
Jan 27, 2025
EPS / Forecast
4.10 / --
Revenue / Forecast
12.30B / --
People Also Watch
FAQ
What Stock Exchange Does Beximco Pharma. Trade On?
Beximco Pharma. is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Beximco Pharma.?
The stock symbol for Beximco Pharma. is "BXPq."
What Is the Beximco Pharma. Market Cap?
As of today, Beximco Pharma. market cap is 318.57M.
What Is Beximco Pharma.'s Earnings Per Share (TTM)?
The Beximco Pharma. EPS (TTM) is 14.24.
From a Technical Analysis Perspective, Is BXPq a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Beximco Pharma. Stock Split?
Beximco Pharma. has split 10 times.
How Many Employees Does Beximco Pharma. Have?
Beximco Pharma. has 1122 employees.
What is the current trading status of Beximco Pharma. (BXPq)?
As of 09 Aug 2025, Beximco Pharma. (BXPq) is trading at a price of 44.50, with a previous close of 44.50. The stock has fluctuated within a day range of 44.50 to 44.50, while its 52-week range spans from 19.33 to 45.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.